SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: Jdaasoc who wrote (34597)2/28/2002 2:52:35 AM
From: JOHN A.  Respond to of 99280
 
Mild acne, the only adverse reaction reported by Imclone



To: Jdaasoc who wrote (34597)2/28/2002 9:18:09 AM
From: Casaubon  Respond to of 99280
 
I would think that any biologic agent that binds to cells should change membrane permability/stability to some degree if you want to see it have a promoting effect when administrated with a traditional anti-cancer drug.

I've always thought the eflux blockers were an interesting angle, though they have not borne fruit (yet?).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News